Related Experiment Videos
Persistent increase in caffeine concentrations in people who stop smoking
N L Benowitz1, S M Hall, G Modin
1Clinical Pharmacology Unit, San Francisco General Hospital Medical Center, CA 94110.
BMJ (Clinical Research Ed.)
|April 22, 1989
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Gender differences in the pharmacology of nicotine addiction.
Addiction biology·2016
Association of CHRNA5-A3-B4 SNP rs2036527 with smoking cessation therapy response in African-American smokers.
Clinical pharmacology and therapeutics·2014
Delayed bupropion cardiotoxicity associated with elevated serum concentrations of bupropion but not hydroxybupropion.
Clinical toxicology (Philadelphia, Pa.)·2013
Genetic and pharmacokinetic determinants of response to transdermal nicotine in white, black, and Asian nonsmokers.
Clinical pharmacology and therapeutics·2013
CYP2A6 genotype but not age determines cotinine half-life in infants and children.
Clinical pharmacology and therapeutics·2013
CYP2B6 and bupropion's smoking-cessation pharmacology: the role of hydroxybupropion.
Clinical pharmacology and therapeutics·2012
Posterior Cerebral Perfusion Associates With Cognitive Improvement After Carotid Endarterectomy in Asymptomatic Stenosis.
Journal of the American Heart Association·2026
Impact of ozone pollution on gross primary productivity during a large-scale emission reduction: Implications for strengthening carbon sink over megacity clusters in China.
Ecotoxicology and environmental safety·2026